Glucosamine negatively affects lumbar discs

Glucosamine negatively affects lumbar discs
Glucosamine supplementation, which is often used for low back pain, has a detrimental effect on lumbar disc matrix homeostasis in an animal model of disc degeneration, according to a study published in the May 20 issue of Spine.
(HealthDay)—Glucosamine supplementation, which is often used for low back pain, has a detrimental effect on lumbar disc matrix homeostasis in an animal model of disc degeneration, according to a study published in the May 20 issue of Spine.

To examine the effect of glucosamine supplementation on intervertebral disc degeneration, Lloydine Jacobs, M.D., from the University of Pittsburgh Medical Center, and colleagues induced in rabbits and treated them with oral glucosamine at 107 mg/day.

After 20 weeks, the researchers found that injured discs from glucosamine-treated animals had lower magnetic resonance imaging indices and areas compared with animals with injured discs without glucosamine supplementation. Glucosamine-treated animals also had reduced glycosaminoglycan as determined by histological and glycosaminoglycan content, and gene expression further supported a detrimental effect of glucosamine on matrix.

"These data demonstrate that the net effect on matrix in an animal model in vivo, as measured by gene expression, , histology, and total proteoglycan, is antianabolic," Jacobs and colleagues conclude. "This raises concern about this commonly used supplement, and future research is needed to establish the clinical relevance of these findings."


Explore further

Glucosamine supplements tied to risk of eye condition

More information: Abstract
Full Text (subscription or payment may be required)
Journal information: Spine

Health News Copyright © 2013 HealthDay. All rights reserved.

Citation: Glucosamine negatively affects lumbar discs (2013, June 29) retrieved 16 June 2019 from https://medicalxpress.com/news/2013-06-glucosamine-negatively-affects-lumbar-discs.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more